This course introduces you to the current unmet need in type 1 diabetes and explores trial data in the use of adjunct therapies including pramlintide, metformin, liraglutide and SGLT-2 inhibitors.
PCClip of the week
When good control still doesn’t prevent complications and beta cell decline: hear Professor Francesco Giorgino on the type 2 paradox, this week in ‘The patient who changed the way I think about diabetes’.
Who, what and why
The EASD has a long and proud history of postgraduate education and the organisation is delighted now to be able to offer online learning as part of this. We are building a suite of e-learning modules designed to educate, inform and engage healthcare professionals around the world.
The wide range of diabetes modules that populate this platform have been designed with the help of international experts in the field of diabetes. They combine innovative multimedia and challenging knowledge checks to help you learn more about this fast-moving area of healthcare and research.
Check out ‘Horizons’, a new section on our site with blogs, news, interviews, videocasts, podcasts and diary dates to help you keep up-to-date with all things diabetes-related.
Available courses
From foot checks to islet transplantation, we are creating and publishing new modules every month.
Insulin-secreting beta cells are central to any understanding of diabetes. This course examines their physiology and significance in the disease processes of type 1 and type 2 diabetes.
PCThis course focuses on cardiovascular health – one of the most significant and challenging aspects of care for type 1 and type 2 diabetes.
PCUsing practical case studies and international guidelines, this course introduces you to treating people with type 1 or type 2 diabetes before, during and after Ramadan.
PCPC
Hajj, the world’s oldest and largest mass gathering, is one of the Five Pillars of Islam. This course considers it in a clinical context, examining how people with diabetes can be supported to perform the rites safely.
PCThis course has been created to introduce you to the diagnosis, consequences and treatment of diabetic kidney disease (diabetic nephropathy).
PCPC
This course outlines key aspects of this important but sometimes neglected complication of diabetes.
PCThis course gives you the tools you need to identify and treat diabetic ketoacidosis (DKA) and to support your patients in avoiding this potentially life-threatening complication.
PCOver time, hyperglycaemia can result in damage to the nerves, with severe consequences for health – not just in the feet but all over the body. This course looks at diabetic neuropathy in all its forms.
PCThis course has been developed to introduce you to the diagnosis of type 1 diabetes and to explore the possible causes of the condition.
PCThis course has been created to introduce you to the epidemiology and current screening controversies of GDM. Treatment, management and the long-term follow-up of women with GDM are also covered.
PCFrom obscure origins in studies of lizard saliva, GLP-1 receptor agonists (GLP-1RAs) have become a staple of type 2 diabetes treatment. This course examines the ways in which they can aid type 2 diabetes management.
PCThis course examines hypoglycaemia, a complication of therapy that has a profound impact on the day-to-day lives and well-being of people who treat their diabetes with insulin.
PCPC
As the incidence of type 2 diabetes continues to explode worldwide, this course gets to grips with the maladapted process at its heart: insulin resistance.
PCPC
Transplants of insulin-producing islets offer the hope of glucose regulation without daily insulin injections. This course looks at advances in this exciting field of diabetes treatment and the challenges still to come.
PCFrom diet and exercise to smoking cessation, lifestyle intervention continues to be a mainstay of diabetes care. This course looks at how to promote lasting behaviour changes for better health.
PCAn introduction to the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) 2018 consensus report and its 2019 update.
PCPC
Surgical intervention to help manage or even reverse type 2 diabetes has gained credence in recent years. This course looks at the theory and the practice.
PCStay safe and keep informed
How do you continue to deliver quality diabetes care during a pandemic? Why are so many of your patients at such high risk of severe infection? And what do non-diabetes specialists caring for people with diabetes in hospital need to know?
To help you get to grips with these and many other questions in this new pandemic era, EASD e-Learning has created a new section on its site, providing you with short, accessible learning from leading experts to help you and your patients stay safe and keep informed. Watch these films to learn more.
Notice board
“Working with the EASD's e-learning team to create a number of different modules on type 1 diabetes from the pathogenesis of the disease to how SGLT-2 inhibitors can work effectively in some patients with the condition has been great. It gave us the opportunity to create innovative and engaging free to access content in many different aspects of type 1 diabetes from basic research to cutting edge clinical trials”
Professor Chantal Mathieu, Belgium
“In a fast paced field like diabetes, it is vital that a trusted name like EASD is offering innovative e-learning modules that are designed to allow people working in the area from around the world a free resource to keep abreast of new research, guidelines and recommendations including the ADA/EASD original consensus report on the management of hyperglycaemia in type 2 diabetes as well as the 2019 update”
Professor Melanie Davies, UK
“Keeping current with all of the developments in the world of diabetes and cardiovascular disease can be difficult. It's been a pleasure to work with the EASD's e-learning team to provide a hub of online modules that are constantly being updated to give you a free, one-stop shop with all the recent research results and what they mean for the treatment of your patients both now and in the future”
Professor Miles Fisher, UK
Develop your knowledge with cutting-edge academic research in an engaging interactive way
Our supporters
European Diabetology
